Publications by authors named "Henk Boot"

Claim this Profile
T
Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial.
Willem J Koemans, Rosa T van der Kaaij, Emma C E Wassenaar, Djamila Boerma, Henk Boot

J Surg Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Hospital Volume With Respect to Performing Gastric Cancer Resection on Recurrence and Survival: Results From the CRITICS Trial.
Yvette H M Claassen, Romy M van Amelsfoort, Henk H Hartgrink, Johan L Dikken, Wobbe O de Steur, Henk Boot

Ann Surg· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients.
Salo N Ooft, Fleur Weeber, Krijn K Dijkstra, Chelsea M McLean, Sovann Kaing, Henk Boot

Sci Transl Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancer.
Laura S Mertens, Mark A Behrendt, Akash M Mehta, Laura Stokkel, Jeroen de Jong, Henk Boot

Eur J Surg Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6).
Koen P Rovers, Checca Bakkers, Geert A A M Simkens, Jacobus W A Burger, Simon W Nienhuijs, Henk Boot

BMC Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.
Astrid E Slagter, Edwin P M Jansen, Hanneke W M van Laarhoven, Johanna W van Sandick, Nicole C T van Grieken, Henk Boot

BMC Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of combined indomethacin and platinum-based chemotherapy to reduce platinum-induced fatty acids.
Daphne L van der Velden, Geert A Cirkel, Julia M Houthuijzen, E van Werkhoven, Jeanine M L Roodhart, Henk Boot

Cancer Chemother Pharmacol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Annemieke Cats, Edwin P M Jansen, Nicole C T van Grieken, Karolina Sikorska, Pehr Lind, Henk Boot

Lancet Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.
Rosa T van der Kaaij, Hidde Jw Braam, Henk Boot, Maartje Los, Annemieke Cats

JMIR Res Protoc· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Wijntje J van Eden, Niels F Kok, Katarzyna Jóźwiak, Max L Lahaye, Geerard L Beets, Henk Boot

Dis Colon Rectum· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based study.
Koen P Rovers, Geert A Simkens, Pauline A Vissers, Valery E Lemmens, Victor J Verwaal, Henk Boot

Eur J Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Müllerian origin from gastrointestinal cancer.
Anna Stiekema, Koen K Van de Vijver, Henk Boot, Annegien Broeks, Catharina M Korse

Cancer Cytopathol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Peritonitis carcinomatosa from colorectal carcinoma: new treatment options].
Victor J Vervaal, Ignace H J T De Hingh, Henk Boot

Ned Tijdschr Geneeskd· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study.
Didier Meulendijks, Laurens V Beerepoot, Henk Boot, Jan Willem B de Groot, Maartje Los

Invest New Drugs· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis.
Maarten J Deenen, Didier Meulendijks, Annemieke Cats, Marjolein K Sechterberger, Johan L Severens, Henk Boot

J Clin Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.
Maarten J Deenen, Didier Meulendijks, Henk Boot, Marie-Cecile J C Legdeur, Jos H Beijnen

Cancer Chemother Pharmacol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study.
Anouk K Trip, Jurriën Stiekema, Otto Visser, Johan L Dikken, Annemieke Cats, Henk Boot

Acta Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-induced dose-dependent changes of the spleen following postoperative chemoradiotherapy for gastric cancer.
Anouk Kirsten Trip, Karolina Sikorska, Johanna W van Sandick, Maarten Heeg, Annemieke Cats, Henk Boot

Radiother Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an r1 resection? Results from a dutch cohort study.
Jurriën Stiekema, Anouk K Trip, Edwin P M Jansen, Mieke J Aarts, Henk Boot

Ann Surg Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new fully covered metal stent with anti-migration features for the treatment of malignant dysphagia.
Daisy Walter, Maarten W van den Berg, Jeanin E van Hooft, Henk Boot, Robert C H Scheffer

Endoscopy· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer.
Jurriën Stiekema, Daan Vermeulen, Erik Vegt, Francine E M Voncken, Berthe M P Aleman, Henk Boot

Clin Nucl Med· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer.
Anouk Kirsten Trip, Jasper Nijkamp, Harm van Tinteren, Annemieke Cats, Henk Boot

Radiother Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy.
Jurriën Stiekema, Anouk K Trip, Edwin P M Jansen, Henk Boot, Annemieke Cats

Ann Surg Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy.
Johan L Dikken, Daniel G Coit, Raymond E Baser, Mithat Gönen, Karyn A Goodman, Henk Boot

Int J Radiat Oncol Biol Phys· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
Maarten J Deenen, Luc Dewit, Henk Boot, Jos H Beijnen, Jan H M Schellens

Int J Radiat Oncol Biol Phys· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis